Double-blind placebo controlled clinical trial of almitrine bismesylate in patients with chronic respiratory insufficiency.

Bakran, I; Vrhovac, B; Stangl, B; Tabori, D; Ivicevic, A; Todic, V; Kandare, F

Bakran, I; Vrhovac, B; Stangl, B; Tabori, D; Ivicevic, A; Todic, V; Kandare, F.

Affiliation

Bakran I; Department of Medicine, University Hospital Rebro, Zagreb, Yugoslavia.

Eur J Clin Pharmacol ; 38(3): 249-53, 1990.

Article in En | MEDLINE | ID: mdl-2187700

Subject(s)

Almitrine/therapeutic use; Lung Diseases, Obstructive/drug therapy; Adult; Aged; Almitrine/adverse effects; Bronchitis/complications; Chronic Disease; Double-Blind Method; Emphysema/complications; Female; Humans; Lung Diseases, Obstructive/etiology; Lung Diseases, Obstructive/physiopathology; Male; Middle Aged; Randomized Controlled Trials as Topic; Respiratory Function Tests

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Almitrine / Lung Diseases, Obstructive Type of study: Clinical_trials / Etiology_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Clin Pharmacol Year: 1990 Document type: Article Affiliation country: Yugoslavia Country of publication: Germany

Search on Google

Add to My VHL

XML

PubMed Links